| Indicators | Browse All

CVRx, Inc. (CVRX)

Healthcare | Medical Devices | Minneapolis, United States | NasdaqGS
1.39 USD +0.05 (3.731%) ⇧ (Oct. 15, 2026, 4 p.m. EDT)

Short-term:★☆☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 5:19 a.m. EDT

The investment case for CVRx is currently broken by a perfect storm of deteriorating fundamentals and aggressive short-term selling. The company is burning cash at an alarming rate, with operating cash flow and free cash flow both deeply negative, while simultaneously cutting guidance despite reporting top-line growth. This disconnect between revenue expansion and cash destruction is a classic value trap signal. The balance sheet is fragile, with debt nearly matching cash reserves and negative returns on equity and assets. While the stock trades at a low multiple relative to sales, the market has correctly priced in the inability to generate sustainable profits or cash flow. Technically, the stock is in a severe downtrend, having lost significant value over the last year and trading well below its moving averages. The recent price action shows continued weakness, with the stock struggling to find support. The statistical forecasting model predicts a slight further decline over the next 45 days, though its reliability is low due to the volatile nature of the price action. Options activity confirms the pessimistic sentiment, with traders positioning heavily for downside protection via puts while avoiding any bullish exposure. There is no speculative capital flowing in to support a recovery. Given the cash burn, the guidance cuts, and the lack of a clear path to profitability, the long-term outlook remains bleak. The stock lacks the fundamental moat or financial strength required for a turnaround story at this stage.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.210339
AutoETS0.210340
AutoTheta0.211556
MSTL0.235032

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 18%
H-stat 23.61
Ljung-Box p 0.000
Jarque-Bera p 0.013
Excess Kurtosis -0.69
Attribute Value
Sector Healthcare
Debt to Equity Ratio 297.649
Revenue per Share 2.325
Market Cap 37,031,820
Forward P/E -0.74
Beta 0.77
Profit Margins -84.93%
Website https://www.barostim.com

As of Oct. 10, 2026, 5:19 a.m. EDT: Speculators are overwhelmingly bearish, evidenced by massive put volume and open interest compared to negligible call activity. Implied volatility for puts is significantly elevated relative to calls, indicating a fear of further downside. The lack of any in-the-money call positioning suggests the market sees the current price as a ceiling rather than a floor.


Info Dump

Attribute Value
52 Week Change -0.8603015
Address1 9,201 West Broadway Avenue
Address2 Suite 650
All Time High 33.135
All Time Low 1.28
Ask 1.39
Ask Size 2
Audit Risk 4
Average Daily Volume10 Day 620,160
Average Daily Volume3 Month 941,375
Average Volume 941,375
Average Volume10Days 620,160
Beta 0.767
Bid 1.36
Bid Size 2
Board Risk 6
Book Value 0.749
City Minneapolis
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 10
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1.39
Current Ratio 8.045
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 1.44
Day Low 1.332
Debt To Equity 297.649
Display Name CVRx
Dividend Yield 0.0
Earnings Call Timestamp End 1,786,048,200
Earnings Call Timestamp Start 1,786,048,200
Earnings Timestamp 1,786,046,400
Earnings Timestamp End 1,793,908,800
Earnings Timestamp Start 1,793,908,800
Ebitda -47,843,000
Ebitda Margins -0.78190005
Enterprise To Ebitda -0.665
Enterprise To Revenue 0.52
Enterprise Value 31,835,820
Eps Current Year -2.0171
Eps Forward -1.87748
Eps Trailing Twelve Months -1.97
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 763 416 2841
Fifty Day Average 2.6212
Fifty Day Average Change -1.2312001
Fifty Day Average Change Percent -0.46970856
Fifty Two Week Change Percent -86.03015
Fifty Two Week High 11.3
Fifty Two Week High Change -9.91
Fifty Two Week High Change Percent -0.8769911
Fifty Two Week Low 1.28
Fifty Two Week Low Change 0.110000014
Fifty Two Week Low Change Percent 0.085937515
Fifty Two Week Range 1.28 - 11.3
Financial Currency USD
First Trade Date Milliseconds 1,625,059,800,000
Float Shares 18,308,638
Forward Eps -1.87748
Forward P E -0.74035406
Free Cashflow -23,801,750
Full Exchange Name NasdaqGS
Full Time Employees 223
Fullday Change 0.03999996
Fullday Change Percent 2.9850717
Fullday Price 1.39
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,790,812,800
Gross Margins 0.86917
Gross Profits 53,183,000
Has Pre Post Market Data 1
Held Percent Insiders 0.10335
Held Percent Institutions 0.66006
Implied Shares Outstanding 26,641,597
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Ipo Expected Date 2,021-06-30
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Long Name CVRx, Inc.
Market us_market
Market Cap 37,031,820
Market State PRE
Max Age 86,400
Message Board Id finmb_1380491
Most Recent Quarter 1,782,777,600
Net Income To Common -51,968,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 72,465,143
Number Of Analyst Opinions 6
Open 1.36
Operating Cashflow -40,457,000
Operating Margins -0.82922995
Overall Risk 9
Phone 763 416 2840
Previous Close 1.34
Price Eps Current Year -0.6891081
Price Hint 4
Price To Book 1.8558077
Price To Sales Trailing12 Months 0.60521376
Profit Margins -0.84932
Quick Ratio 6.651
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.05
Regular Market Change Percent 3.73134
Regular Market Day High 1.44
Regular Market Day Low 1.332
Regular Market Day Range 1.332 - 1.44
Regular Market Open 1.36
Regular Market Previous Close 1.34
Regular Market Price 1.39
Regular Market Time 1,792,094,401
Regular Market Volume 360,491
Return On Assets -0.28698
Return On Equity -1.3344501
Revenue Growth 0.156
Revenue Per Share 2.325
Sand P52 Week Change 0.16207206
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 8
Shares Outstanding 26,641,597
Shares Percent Shares Out 0.0744
Shares Short 1,982,426
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 1,968,589
Short Name CVRx, Inc.
Short Percent Of Float 0.1042
Short Ratio 2.68
Source Interval 15
State MN
Symbol CVRX
Target High Price 6.0
Target Low Price 3.5
Target Mean Price 4.58333
Target Median Price 4.5
Total Cash 64,586,000
Total Cash Per Share 2.424
Total Debt 59,390,000
Total Revenue 61,188,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.97
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 5.6135
Two Hundred Day Average Change -4.2235003
Two Hundred Day Average Change Percent -0.7523827
Type Disp Equity
Volume 360,491
Website https://www.barostim.com
Zip 55,445